Diamond Biotechnology Co., Ltd (TPEX:6815)
Taiwan
· Delayed Price · Currency is TWD 35.50
+5.10 (16.78%)
Apr 29, 2026, 1:59 PM CST
Diamond Biotechnology Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Market Capitalization | 1,429 | 2,707 | 2,416 | 865 | 975 | - | Upgrade
|
| Market Cap Growth | -29.54% | 12.05% | 179.34% | -11.33% | - | - | Upgrade
|
| Enterprise Value | 1,473 | 2,785 | 2,686 | 1,023 | 1,086 | - | Upgrade
|
| Last Close Price | 35.95 | 67.85 | 65.38 | 23.37 | 26.25 | - | Upgrade
|
| PE Ratio | 40.51 | 36.98 | 51.69 | 25.90 | 23.27 | - | Upgrade
|
| PS Ratio | 2.05 | 3.52 | 3.92 | 1.99 | 2.47 | - | Upgrade
|
| PB Ratio | 2.31 | 4.35 | 6.97 | 2.86 | 3.57 | - | Upgrade
|
| P/TBV Ratio | 2.32 | 4.37 | 7.13 | 2.98 | 3.83 | - | Upgrade
|
| P/FCF Ratio | 25.78 | 610.22 | - | 10.23 | - | - | Upgrade
|
| P/OCF Ratio | 22.46 | 80.33 | 59.06 | 5.49 | 172.78 | - | Upgrade
|
| EV/Sales Ratio | 2.11 | 3.63 | 4.36 | 2.35 | 2.75 | - | Upgrade
|
| EV/EBITDA Ratio | 19.63 | 21.18 | 29.36 | 13.84 | 13.63 | - | Upgrade
|
| EV/EBIT Ratio | 29.71 | 25.71 | 42.03 | 22.14 | 22.67 | - | Upgrade
|
| EV/FCF Ratio | 26.57 | 627.84 | - | 12.10 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.40 | 0.40 | 0.97 | 0.65 | 0.62 | 0.58 | Upgrade
|
| Debt / EBITDA Ratio | 3.32 | 1.85 | 2.95 | 1.99 | 1.61 | 1.95 | Upgrade
|
| Debt / FCF Ratio | 4.49 | 56.71 | - | 2.33 | - | 9.13 | Upgrade
|
| Net Debt / Equity Ratio | 0.07 | 0.01 | 0.74 | 0.33 | 0.43 | 0.31 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.61 | 0.04 | 2.82 | 1.34 | 1.49 | 1.68 | Upgrade
|
| Net Debt / FCF Ratio | 0.79 | 1.24 | -1.65 | 1.17 | -6.15 | 4.91 | Upgrade
|
| Asset Turnover | 0.69 | 0.83 | 0.86 | 0.74 | 0.81 | 0.68 | Upgrade
|
| Inventory Turnover | 2.74 | 4.10 | 4.04 | 2.83 | 2.60 | 3.07 | Upgrade
|
| Quick Ratio | 2.29 | 2.37 | 1.05 | 0.81 | 1.18 | 1.22 | Upgrade
|
| Current Ratio | 3.55 | 3.28 | 1.50 | 1.22 | 1.77 | 1.87 | Upgrade
|
| Return on Equity (ROE) | 5.72% | 15.10% | 14.40% | 11.60% | 16.59% | 4.58% | Upgrade
|
| Return on Assets (ROA) | 3.06% | 7.30% | 5.59% | 4.93% | 6.12% | 2.06% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.44% | 13.44% | 10.18% | 9.31% | 11.07% | 3.82% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.10% | 12.80% | 12.00% | 14.10% | 14.10% | 4.90% | Upgrade
|
| Earnings Yield | 2.46% | 2.70% | 1.93% | 3.86% | 4.30% | - | Upgrade
|
| FCF Yield | 3.88% | 0.16% | -6.45% | 9.78% | -1.97% | - | Upgrade
|
| Dividend Yield | 0.55% | 0.24% | 0.21% | 0.36% | 0.40% | - | Upgrade
|
| Payout Ratio | 14.07% | 6.76% | 6.47% | 11.42% | 2.37% | 265.00% | Upgrade
|
| Buyback Yield / Dilution | -7.30% | -4.92% | -1.02% | 0.00% | -3.35% | -17.19% | Upgrade
|
| Total Shareholder Return | -6.74% | -4.68% | -0.81% | 0.36% | -2.95% | -17.19% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.